Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
GP130/STAT3 signalling in articular cartilage development and regeneration
Summer Research Experience in Biological and Computational Sciences
A novel data science and network analysis approach to quantifying facilitators and barriers of low tidal volume ventilation in an international consortium of medical centers
National Lung Screening Trial (NLST)
Photochemistry of Azide Based Cross-Linkers in Water
Recently added grants:
Human neutralizing antibodies for Zika virus
Combining Systems Pharmacology Modeling With Machine Learning To Identify Sub-Populations At Risk Of Drug-Induced Torsades de Pointes
Examining the long-term relationship between sleep and diet
Vasopressin and Preeclampsia: Early Mechanisms for Prevention
A new paradigm of short stature: Incorporating parent and youth characteristics into understanding GH-related decision making and trajectories of quality of life and self-esteem
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43309-8-0-1
Application #
7587179
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/ Fox Chase Cancer Center
$2,364,525
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
Clapper, Margie /
$1,632,611
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/
Comments
Be the first to comment on this grant